<DOC>
	<DOCNO>NCT00790985</DOCNO>
	<brief_summary>To compare flavocoxid naproxen patient moderate severe osteoarthritis knee .</brief_summary>
	<brief_title>Efficacy Flavocoxid Compared With Naproxen Subjects With Moderate-severe Osteoarthritis Knee</brief_title>
	<detailed_description>Efficay flavocoxid compare naproxen subject moderate-severe osteoarthritis knee .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Naproxen</mesh_term>
	<criteria>Willing able read understand inform consent questionnaire English . Adults either gender age 3575 year , general good health . Established Xray diagnosis osteoarthritis least one knee . Taken NSAID include COX2 inhibitor full therapeutic dose least one month prior screen . Able discontinue OA medication flare criterion meet . BMI &lt; /= 45 Subjects must rate target knee least 5 10 discomfort VAS baseline visit . Have increase least 15mm 100mm pain VAS screen baseline visit . Must use acceptable birth control female . Screening fecal occult must negative . Able attend require visit Physical Therapy allow long type frequency remain unchanged duration study . Refusal sign consent . Inability attend clinic visit Grade 01 KL change knee grade 4 KL change either knee standing A/P radiograph Pregant lactate woman History serious cardiovascular disease . Recurrent arrythmias , except PAT , cardiomyopathy , MI within one year screening . History chronic esophageal , gastric duodenal disease History upper GI bleeding within past 2 year . Any GI disorder associate malabsorption Any musculoskeletal neurological condition result pain gait disturbance might confound evaluation target knee . Uncontrolled Diabetes Mellitus History bleed disorder concurrent use coumadin agent use reduce blood clot platelet adhesiveness . Concurrent use antiarthritic medication , include corticosteroid regardless reason use . ( low dose aspirin cardioprotection allow ) History chronic renal disease creatinine &gt; 2.0 nephrotic syndrome 24 hour protein excretion &gt; 1000mg . Intraarticular injection hyaluronic acid preparation target knee joint within 4 month baseline visit . Intraarticular injection corticosteroid target knee joint within 2 month baseline visit . BMA &gt; 45 History allergic reaction flavonoid flavan containg food product ( example : red wine , color fruit vegetable , brazel nut , tea , natto ) History allergy aspirin , naproxen NSAID History substance abuse include alcohol , psychiatric condition may impair subject 's ability comply study requirement . Any medical condition , opinion investigator , might put subject undue risk might interfere subject 's ability participate study . Participation another clinical trial within 30 day 7 half life study agent , whichever longer , screen visit .</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>